Description of Past Management: Daily application of enzymatic debridement therapy was initiated with once a week conservative sharps debridement at bedside. Non-contact low frequency ultrasound (NLFU) was also initiated. Inspite of the combined treatment modalities, wound bed continues to be necrotic and non-responsive to treatments.
Current Clinical Approach: Biosurgical therapy was initiated to assist with the different methods of debridement. Larvae that have been applied in the wound bed was sealed within a finely woven polyester net dressing and remained in the wound throughout the treatment. Larval secretions penetrated through the dressing where non-viable tissue was liquefied. Bagged larvae was left in the wound for four days and covered with a saline wet to moist dressing, periwound skin was protected with zinc oxide ointment.
Patient Outcomes: Bagged larvae was applied for three consecutive times in a period of 15 days. Non-viable tissues have been effectively removed through biosurgical therapy. Wound volume has decreased from 71.4cm2 to 28.7cm2.
Conclusion: Biosurgical therapy is an innovative delivery system and clinically effective in reducing bioburden. It allows clinicians to debride wounds with precision while maintaining patients comfort. The ease of application and shorter debridement times make this method a cost efficient debridement solution for slow and non-healing wounds.